<!doctype html>
<html lang="zh-CN">
<head>      <!-- 动态设置基础路径，适应 GitHub Pages 和本地开发 -->
  <script>
    // 自动检测基础路径 - 修复GitHub Pages路径问题
    let basePath = '/';
    
    // 获取当前URL的路径部分和主机名
    const currentPath = window.location.pathname;
    const hostname = window.location.hostname;
    
    // 检查是否在GitHub Pages上（通过主机名判断）
    if (hostname.endsWith('.github.io')) {
      // GitHub Pages URL结构：https://username.github.io/repository-name/
      // 所以路径中第一个非空部分是仓库名称
      const pathParts = currentPath.split('/').filter(Boolean);
      if (pathParts.length > 0) {
        basePath = '/' + pathParts[0] + '/';
      }
    }
    
    // 调试信息，可在浏览器控制台查看
    console.log('Dynamic base path set to:', basePath, 'Hostname:', hostname, 'Current path:', currentPath);
    
    // 创建并添加 base 标签
    const base = document.createElement('base');
    base.href = basePath;
    document.head.insertBefore(base, document.head.firstChild);
  </script>  <!-- 鍔ㄦ€佽缃熀纭€璺緞锛岄€傚簲 GitHub Pages 鍜屾湰鍦板紑鍙?-->
  <script>
    // 鑷姩妫€娴嬪熀纭€璺緞
    const basePath = window.location.pathname.startsWith('/izju-china-wiki-remake/') 
      ? '/izju-china-wiki-remake/' 
      : '/';
    // 鍒涘缓骞舵坊鍔?base 鏍囩
    const base = document.createElement('base');
    base.href = basePath;
    document.head.insertBefore(base, document.head.firstChild);
  </script>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta charset="utf-8">
  <title>Human Practices</title>
  <link rel="stylesheet" href="/assets/css/styles.css">

  <link rel="stylesheet" href="/static/ihp-typography.css">
</head>
<body>
  <button class="sidebar-toggle" aria-label="鍒囨崲瀵艰埅" aria-expanded="false">鈽?/button>
  <aside class="sidebar">
<a class="home" href="/"><img src="/assets/images/menu.webp" alt="涓婚〉"></a>
<!--SIDEBAR-START-->
<!-- 鏈枃浠剁敱 inject-sidebar.js 鑷姩鐢熸垚 -->
<nav class="site-nav">
  <ul>
    <li><a href="/" class="home-link">Home</a></li>
    <li><span>Project</span>
  <ul>
<li><a href="/pages/1Project/1background.html">Background</a></li>
<li><a href="/pages/1Project/2description.html">Description</a></li>
<li><a href="/pages/1Project/3engineering.html">Engineering</a></li>
<li><a href="/pages/1Project/4contribution.html">Contribution</a></li>
<li><a href="/pages/1Project/5implementation.html">Implementation</a></li>
<li><a href="/pages/1Project/6project-future.html">Future Directions</a></li>  </ul>
</li>
<li><span>Dry Lab</span>
  <ul>
<li><a href="/pages/2Dry Lab/1design.html">Design</a></li>
<li><a href="/pages/2Dry Lab/2model.html">Model</a></li>  </ul>
</li>
<li><span>Wet Lab</span>
  <ul>
<li><a href="/pages/3Wet Lab/1wetlab-overview.html">Wet Lab Overview</a></li>
<li><a href="/pages/3Wet Lab/2gene-cleavage.html">Gene Cleavage Module</a></li>
<li><a href="/pages/3Wet Lab/3assembly.html">Assembly Module</a></li>
<li><a href="/pages/3Wet Lab/4validation.html">Functional Validation</a></li>
<li><a href="/pages/3Wet Lab/5wetlab-future.html">Future Directions</a></li>
<li><a href="/pages/3Wet Lab/6parts.html">Parts</a></li>  </ul>
</li>
<li><span>Human Practice</span>
  <ul>
<li><a href="/pages/4Human Practice/1human-practices.html">Human Practices</a></li>
<li><a href="/pages/4Human Practice/2entrepreneurship.html">Entrepreneurship</a></li>
<li><a href="/pages/4Human Practice/3collaborations.html">Collaboration</a></li>
<li><a href="/pages/4Human Practice/4safety.html">Safety</a></li>  </ul>
</li>
<li><span>Team</span>
  <ul>
<li><a href="/pages/5Team/1roster.html">Team Roster</a></li>
<li><a href="/pages/5Team/3awards.html">Awards</a></li>  </ul>
</li>

  </ul>
</nav>
<!--SIDEBAR-END-->
<a class="back-to-top" href="#" title="鍥炲埌椤堕儴"><img src="/assets/images/uptotop.webp" alt="鍥炲埌椤堕儴"></a>
</aside>

  <main class="content">
<div class="pagecontainer"><div class="title2"><span>Human Practices</span></div></div>

    <div class="pagecontent" id="auto-page-content"><aside id="toc" class="toc"></aside><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In the <strong>Human Practices</strong> journey, we demonstrate how we combined scientific ambition with real-world responsiveness, stakeholder integration, effective communication, and ethical reflection. Our project evolved from a conceptual sketch into a data-driven, clinically informed, and socially grounded universal platform against antimicrobial resistance (AMR). At every stage, feedback from experts, stakeholders, and the public reshaped both our technical design and our communication strategies.</p>

<h1 style="color: #ffffff !important; text-shadow: 0 0 50px rgba(96, 165, 250, 1), 0 0 30px rgba(96, 165, 250, 0.9), 0 0 15px rgba(96, 165, 250, 0.7);">Responsiveness</h1>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In the <strong>Responsiveness</strong> section, we focus on how to <strong>respond to urgent problems at both social and scientific levels</strong>. Antimicrobial resistance (<strong>AMR</strong>) is coupling <strong>resistance</strong> with <strong>infectiousness/transmissibility</strong> into a self-reinforcing positive feedback loop. Resistance causes treatment failure and prolongs the <strong>infectious period</strong>, while a longer infectious period increases population-level transmission intensity (often reflected as higher <strong>R鈧€</strong>, the <em>basic reproduction number</em>). Pathogens like <strong>MRSA</strong>, which combine strong resistance with high transmissibility, are therefore extremely difficult to control in both hospital and community settings.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Our actions in the Responsiveness part include literature review, data analysis, mathematical modeling, and social feedback, to demonstrate the real urgency of the problem and confirm that converting MRSA back to MSSA is the most rational response.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Real-world urgency</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Multiple epidemiological studies have quantified the burden of AMR: <strong>drug-resistant bacterial infections directly caused about 1.27 million deaths annually</strong>, with overall associated mortality even higher, and the burden disproportionately severe in low- and middle-income countries. For MRSA specifically, <strong>environmental and hospital surfaces show positivity rates of 2.5鈥?.8%</strong>, with <strong>46.3% identified as coagulase-negative staphylococci (CoNS)</strong>. CoNS often serve as the <strong>gene reservoir/intermediate host for mecA/SCCmec</strong>, facilitating the circulation and reintroduction of resistance within the <em>Staphylococcus</em> population. In addition, HA-MRSA and CA-MRSA harbor different SCCmec types (II/III vs. IV), combining multidrug resistance with high transmissibility, further complicating infection control in hospitals and communities.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In the Responsiveness stage, we highlight these data as background evidence to address societal concerns about whether MRSA truly represents a pressing and urgent threat.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">SIRD and Competition Models</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">To validate the principle that "<strong>resistance = transmission advantage</strong>," we used mathematical models to test whether converting MRSA back to MSSA is dynamically reasonable and necessary.</p>

<p style="margin-left:0; text-indent:0;font-size:18px;">
  <strong>SIRD (Susceptible鈥揑nfected鈥揜ecovered鈥揇eceased) model</strong><br>
  In this framework, "treatment failure or delay caused by resistance" is represented as a 
  <strong>decrease in recovery rate 纬</strong> (i.e., prolonged infectious period), which increases 
  <strong>R鈧€ (= 尾/纬)</strong> at the same transmission rate 尾. Simulations showed: 
  <strong>MRSA, compared with MSSA, has a later and higher peak, with a longer tail</strong>, 
  a classic "<em>long tail</em> effect." This means that as long as resistance exists, outbreaks 
  are both larger and more persistent. The causal chain (longer infectious period 鈫?higher R鈧€) 
  is transparent in the model and aligns with clinical intuition.
</p>
<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-1.webp" alt="SIRD Model"></p>

<p style="margin-left:0; text-indent:0;font-size:18px;">
  <strong>Resistant鈥搒ensitive competition model</strong><br>
  We further incorporated an "<strong>antibiotic selection pressure</strong>" term to reflect combination or rotational therapies.
  Under this setting, resistant strains gain higher <strong>relative fitness</strong> during drug exposure.
  The model showed: <strong>even when MSSA initially dominates, MRSA eventually overtakes and replaces it under sustained antibiotic pressure</strong>.
  This mirrors the clinical reality of infections becoming increasingly difficult to treat and resistance spectra expanding over time.
</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-2.webp" alt="Competition Model"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Thus, simply escalating or switching antibiotics only strengthens the competitive advantage of resistance. A more systemic strategy is to <strong>convert MRSA back to MSSA</strong>, removing the "long-tail advantage" of resistance and restoring the system to a "treatable鈥搎uickly cleared" trajectory.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Predictive value of mecA</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Instead of analyzing broad resistance genes, we focused specifically on <strong>mecA</strong>: is it stable and informative enough to serve as a <strong>priority target for de-resistance</strong>?</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We analyzed <strong>989 isolates</strong> from the NCBI <em>S. aureus</em> Pathogen Detection Browser (2024-01-01 to 2025-01-01), with both AMR genotypes and AST phenotypes available.</p>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Coherence</strong>: Among all methicillin-resistant isolates, <strong>95.8%</strong> carried <strong>mecA</strong>, demonstrating strong genotype鈥損henotype consistency.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Discriminative power</strong>: Logistic regression and ROC analysis showed that <strong>mecA predicts composite methicillin resistance (MET鈭狾XA鈭狥OX) with AUC = 0.967</strong>, sensitivity 95.8%, specificity 97.6%. For individual drugs: OXA AUC = 0.944; FOX AUC = 0.829. Thus, mecA alone achieves high-precision population-level classification.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Effect size</strong>: Composite methicillin resistance showed <strong>OR = 352.2 (95% CI 162.8鈥?61.9)</strong>; intercept OR = 0.016 (indicating near-zero resistance when mecA-negative). This is a magnitude-level effect, identifying mecA as a <strong>high-value, actionable target</strong>.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Interpretability</strong>: Confusion matrices (e.g., OXA: TP = 243, FN = 8, FP = 42, TN = 487) further confirmed strong dependency. This provides a clear engineering loop: <strong>delete mecA 鈫?loss of PBP2a 鈫?尾-lactams regain efficacy 鈫?MRSA 鈫?MSSA</strong> (epidemiologically equivalent to shortening infectious period, lowering R鈧€, and flattening the long tail).</li>
</ul>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-2-3.webp" alt="mecA Analysis"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In Responsiveness, this analysis serves as <strong>data-driven justification for our design</strong>: targeting mecA directly dismantles MRSA's resistance advantage.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Literature cross-validation</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We also cross-validated our findings with existing literature, addressing external concerns about consistency with scientific consensus.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Evidence confirms: <strong>CoNS act as reservoirs/intermediate hosts for SCCmec</strong>, <strong>environmental and hospital surfaces repeatedly detect MRSA/CoNS</strong>, and <strong>HA-MRSA and CA-MRSA differ in SCCmec types</strong>, reflecting ecological adaptation. Together, these factors establish that "resistance persists through cross-host, cross-environment circulation." This aligns with our strategic orientation: <strong>rather than racing against resistance, remove it altogether</strong>.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Survey: Public awareness and acceptance</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">As part of Responsiveness, we conducted surveys among the public and medical students, focusing on:</p>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Awareness of AMR;</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Acceptance of gene editing and de-resistance strategies;</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Concerns over safety, controllability, and risks.</li>
</ul>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">A total of 306 sets of data were received from various parts of China, with the majority coming from the central and eastern regions of China.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-3.webp" alt="Survey Distribution"></p>

<h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">Awareness of AMR</h3>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Perceived harm</strong>: Only <strong>9.5%</strong> rated themselves as "very knowledgeable," while <strong>42.8%</strong> reported "limited or no knowledge," showing a general lack of awareness of the AMR crisis.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Prevention awareness</strong>: Only <strong>5.6%</strong> considered themselves "very knowledgeable," while <strong>68%</strong> admitted limited understanding, highlighting major knowledge gaps in resistance mechanisms and prevention methods.</li>
</ul>

<h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">Attitudes toward novel gene-editing therapy</h3>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">When asked about "using DNA origami to deliver CRISPR-Cas9 to remove resistance genes," 79.7% responded "supportive" or "very supportive," with only 2% opposed. This indicates high acceptance of innovative approaches.</p>

<h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">AMR awareness vs. gene-editing support</h3>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Among those with <strong>low awareness</strong>, opposition rates were higher (~10%).</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Among those with <strong>high awareness</strong>, support exceeded 90%, with significantly more "very supportive."</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Chi-square test (蠂虏 = 33.36, df = 9, <strong>p &lt; 0.001</strong>) confirmed significant correlation: <strong>higher AMR awareness predicts stronger support for gene editing</strong>.</li>
</ul>

<h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">Attitudes toward gene editing vs. interest in educational tools</h3>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Among <strong>supporters of gene editing</strong>, over <strong>75%</strong> expressed interest in interactive wiki tools.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Among <strong>skeptics or opponents</strong>, interest dropped below 40%.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Chi-square test (蠂虏 = 17.13, df = 9, <strong>p = 0.047</strong>) confirmed significant correlation: <strong>supportive attitudes predict stronger interest in interactive tools</strong>.</li>
</ul>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">These results show that <strong>technical acceptance and learning willingness are coupled</strong>: those who accept new technology are more eager to engage with explanatory tools. This validates our plan to build an <strong>interactive wiki module on DNA origami鈥揅RISPR</strong>, not just as outreach, but as an <strong>educational intervention to reduce public concerns</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">The survey revealed: <strong>public awareness of AMR is low, but acceptance of de-resistance gene editing is high</strong>; moreover, <strong>awareness strongly correlates with support</strong>, and <strong>attitude strongly correlates with willingness to learn</strong>. This means that only by making society understand the dual threat of "resistance + transmissibility" can people truly accept the MRSA鈫扢SSA strategy and actively participate in learning through interactive science communication.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We identified public cognitive gaps and social expectations through questionnaires and significance analysis. In the project, we simultaneously advanced "scientific design for de-drug resistance" and "social response of information transparency + interactive popular science" to ensure the dual realization of scientific rationality and public acceptability.</p>

<h1 style="color: #ffffff !important; text-shadow: 0 0 50px rgba(96, 165, 250, 1), 0 0 30px rgba(96, 165, 250, 0.9), 0 0 15px rgba(96, 165, 250, 0.7);">Integration</h1>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Stakeholder Analysis</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Our project started as a scientific idea, but for it to become meaningful and impactful, it had to be understood, supported, and eventually adopted by the right stakeholders. We recognized early that antimicrobial resistance (AMR) is not just a laboratory challenge but a societal issue that affects clinicians, patients, hospitals, regulatory agencies, and industry. Therefore, before building our timeline of iterative improvements, we first conducted a <strong>Stakeholder Analysis</strong> to clarify <strong>who matters most to our project</strong> and <strong>how their perspectives could guide our design choices</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-4.webp" alt="Stakeholder Analysis"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We used a <strong>Power鈥揑nterest Grid</strong> to map stakeholders according to their influence and level of concern regarding AMR solutions.</p>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Clinicians</strong>: Highly interested in effective therapies but with limited procurement power.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Large hospitals</strong>: Both powerful and interested, making them our <strong>core stakeholders</strong>.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Community hospitals</strong>: Lower interest and power, but potential secondary adopters in later stages.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Research institutes</strong>: High scientific interest, providing validation but limited deployment authority.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Public health agencies</strong>: Very powerful in shaping policies and funding decisions, with variable interest depending on public health impact.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Pharma/biotech companies</strong>: Initially low interest, but high long-term power to industrialize.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Livestock and veterinary sectors</strong>: Currently low interest and willingness to pay unless policy-driven.</li>
</ul>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/stakeholders.webp" alt="Stakeholder Analysis"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">This mapping exercise revealed that our <strong>short-term credibility depends on clinicians and hospitals</strong>, our <strong>mid-term scalability relies on public health agencies and research institutes</strong>, and our <strong>long-term sustainability will hinge on industry partnerships</strong>. By clarifying these roles, we could better align our interviews, collaborations, and communication strategies with the needs of each group.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">The Stakeholder Analysis became the foundation of our Integration strategy. It not only shaped the sequence of our timeline but also explained <strong>why certain feedback loops mattered more than others</strong>. By embedding stakeholder perspectives into our design, our project evolved from a purely technical idea into a <strong>socially responsive and practically feasible platform</strong>.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Timeline</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Our Human Practices journey was not a linear path but a continuous cycle of <strong>Anticipation, Reflection, Engagement, and Action (AREA)</strong>. Starting from a conceptual sketch of a DNA origami鈥揅as9 platform, our project gradually evolved into a <strong>data-driven, clinically informed, and socially grounded universal platform against antimicrobial resistance (AMR)</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Each step in the timeline reflects how we combined <strong>wet-lab, dry-lab, and HP efforts</strong>: from professor consultations and epidemiological modeling, to stakeholder interviews with doctors, nurses, and pharmacists, to exchanges with companies and iGEM peers. At every stage, feedback reshaped both our technical design and our communication strategies.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">This integration timeline demonstrates how our project grew through <strong>real-world feedback loops</strong>, transforming initial ideas into a platform that is not only <strong>scientifically feasible</strong> but also <strong>clinically relevant, socially responsible, and commercially aware</strong>.</p>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" style="text-align: center; margin: 2rem auto; max-width: 100%;">
  <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-6-1.webp" alt="Integration Timeline" style="width: 65%; max-width: 1200px; border: 2px solid #e2e8f0; border-radius: 12px; box-shadow: 0 10px 25px rgba(0, 0, 0, 0.1);">
</div>


<!-- Timeline 0: Leaders Brainstorm -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#leadersModal">
    <span class="circle">1</span>
    <span class="label">Leaders Brainstorm: Project Blueprint</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="leadersModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">

    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">0. Leaders Brainstorm: Project Blueprint</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-1.webp"
           alt="Timeline 0"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      At the very beginning, our team framed the project as a
      <strong>platform against antimicrobial resistance (AMR)</strong>.
      The vision was to design a modular system that could, in principle,
      be adapted to different resistant bacteria by swapping targeting elements,
      while keeping the delivery and safety framework universal.
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      We chose methicillin-resistant <em>Staphylococcus aureus</em> (MRSA)
      as a <strong>representative model pathogen</strong>:
    </p>

    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">MRSA is one of the most notorious 鈥渟uperbugs鈥?worldwide.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Its resistance is largely mediated by a single gene, <em>mecA</em>, which makes it a practical entry point for proof of concept.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">MRSA infections impose a heavy clinical and societal burden, thus aligning our project with urgent public health needs.</li>
    </ul>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The <strong>v0 design</strong> of the platform included:
    </p>

    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">A DNA origami cylinder encapsulating <strong>sgRNA/Cas9 complexes</strong> to cleave resistance genes (starting with <em>mecA</em>).</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>G4鈥揾emin clusters</strong> at both ends to catalyze H鈧侽鈧?into reactive oxygen species (ROS), enabling <strong>bacterial membrane permeabilization</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Disulfide bond locking strands</strong> to protect Cas9 cargo and allow <strong>glutathione-triggered release</strong> inside bacterial cytoplasm.</li>
    </ul>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      While the system was theoretically elegant, at this stage it remained a
      <strong>concept sketch</strong>: it had not yet been validated experimentally,
      modeled quantitatively, or examined for ethical and societal acceptance.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To build a <strong>universal platform</strong> against resistant bacteria, adaptable to different pathogens.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To align the project with the <strong>Infectious Diseases track</strong>, while using MRSA as a representative model.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To integrate wet-lab, dry-lab, and Human Practices into one unified design framework.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To provide a baseline for future refinement through validation and stakeholder feedback.</li>
    </ol>

    <h4>Process</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">During our initial brainstorming, the platform workflow was outlined as follows:</p>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">DNA origami assembly with G4 modifications.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Encapsulation of sgRNA/Cas9 targeting a resistance gene.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">ROS-mediated membrane permeabilization for bacterial entry.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Controlled disulfide-lock release inside the cytoplasm.</li>
    </ol>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Key uncertainties quickly surfaced:</p>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Could ROS-mediated permeabilization be strong enough against bacterial membranes yet safe for host tissues?</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Would Cas9 remain functional during transport?</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Could the platform be adapted to other pathogens in practice?</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Would regulators, clinicians, and the public accept a 鈥済ene-editing antibacterial platform鈥?</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The v0 blueprint gave us a <strong>universal vision but lacked real-world grounding</strong>.
      Without background data, modeling, or ethical validation, it risked being dismissed
      as over-idealized. We recognized that a platform must prove itself not only technically
      but also in terms of <strong>safety, adaptability, and social legitimacy</strong>.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To seek professor's guidance on biosafety and feasibility.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To conduct a literature review and database screening to confirm <em>mecA</em> as a model target.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To initiate Human Practices interviews with clinicians, nurses, pharmacists, and the public.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To prepare wet-lab and dry-lab validation modules for stability, activity, and delivery efficiency.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='description') }}" target="_blank">Project Description</a>
    </p>

  </div>
</div>


<!-- Timeline 1: Professor Consultation -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#profModal">
    <span class="circle">2</span>
    <span class="label">Professor Consultation</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="profModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">1. Professor Consultation</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-2.webp"
           alt="Timeline 1"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      After the initial v0 blueprint, our team reached out to faculty advisors for early guidance on biosafety and targeting strategies. While the DNA origami, Cas9 concept was promising, two unresolved questions emerged:
    </p>

    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Safety</strong> 鈥?Direct work with MRSA and <em>mecA</em> posed unacceptable biosafety risks for a student team.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Targeting</strong> 鈥?The v0 blueprint lacked a robust mechanism for ensuring selective entry into resistant bacteria.</li>
    </ol>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      This consultation became a turning point where our project transitioned from a <strong>conceptual sketch</strong> to a <strong>structured roadmap with safety and targeting modules</strong>.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To redesign the validation route in compliance with iGEM biosafety standards.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To decide on a specific targeting mechanism for bacterial recognition.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To establish a computational-experimental workflow for aptamer selection and evaluation.</li>
    </ol>

    <h4>Process</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">During consultation, professors emphasized two directions:</p>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Biosafety</strong>: Direct MRSA handling was not feasible. They advised us to adopt a <strong>surrogate validation system</strong>, leading us to replace <em>mecA</em> with <em>lacZ</em> for early in vivo experiments, while retaining <em>mecA</em> as the ultimate in vitro validation target.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Targeting specificity</strong>: To improve selectivity, professors encouraged us to incorporate <strong>aptamers</strong> that could recognize bacterial surface components.</li>
    </ul>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Following this guidance, our team launched a <strong>Dry-Lab screening and modeling pipeline</strong> for aptamer design:</p>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Database search for candidate aptamers.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>MOE docking</strong> to evaluate interaction with bacterial surface proteins.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>mfold</strong> for secondary structure prediction.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>RNAcomposer</strong> for 3D folding analysis.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Aptatrans (deep learning tool)</strong> for final binding affinity scoring.</li>
    </ol>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      This pipeline allowed us to rationally choose aptamers with high predicted binding strength and structural stability, which would then guide wet-lab validation.
    </p>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">This combined step marked a double refinement of our project:</p>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">By switching to <strong><em>lacZ</em> surrogate validation</strong>, we aligned our wet-lab work with biosafety requirements.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">By integrating <strong>aptamer targeting with computational screening</strong>, we added precision and adaptability to the platform.</li>
    </ul>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      It also clarified our identity: not a one-pathogen therapy, but a <strong>universal, safe, and adaptable platform against resistant bacteria</strong>.
    </p>

    <h4>Action</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Replaced <em>mecA</em> with <em>lacZ</em> in initial in vivo validation to ensure safety.</p>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Retained <em>mecA</em> as the ultimate in vitro validation target.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Established a <strong>Dry-Lab aptamer screening and modeling workflow</strong> to select optimal candidates.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Updated our Safety documentation and project roadmap accordingly.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='gene-cleavage') }}" target="_blank">Wet-Lab lacZ</a> 路
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='safety') }}" target="_blank">Safety</a> 路
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='model') }}" target="_blank">Aptamer Modeling</a>
    </p>

  </div>
</div>


<!-- Timeline 2: Validating mecA and MRSA Burden -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#mecaModal">
    <span class="circle">3</span>
    <span class="label">Validating mecA and MRSA Burden</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="mecaModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">2. Validating mecA and MRSA Burden</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-3.webp"
           alt="Timeline 2"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      To strengthen our platform concept, we recognized the need for <strong>solid data evidence</strong>. Without clear epidemiological and genetic justification, our design risked being dismissed as purely theoretical. Therefore, we carried out three streams of background support:
    </p>

    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Literature review</strong> of AMR and MRSA to establish the clinical and societal burden.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Database analysis</strong> of <em>mecA</em> to validate it as a reliable genetic marker of resistance.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Mathematical modeling</strong> (SIRD and competition models) to quantify MRSA transmission compared to MSSA.</li>
    </ol>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To demonstrate the global importance of MRSA within the AMR crisis.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To confirm <em>mecA</em> as a valid and specific marker of resistance.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To model MRSA infection dynamics and show why targeting it brings public health benefits.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Through <strong>literature review</strong>, we collected WHO reports and high-impact publications demonstrating that MRSA causes significant morbidity and mortality, and is one of the 鈥淓SKAPE鈥?pathogens prioritized for global research.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Using the <strong>NCBI Pathogen Detection database (~1000 isolates)</strong>, we showed that the presence of <em>mecA</em> strongly correlated with the resistant phenotype, with high ROC performance, confirming it as a credible gene target.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">By building <strong>SIRD and competition models</strong>, we compared MRSA with methicillin-sensitive <em>S. aureus</em> (MSSA). The models showed that MRSA exhibits a longer infectious period and higher mortality, amplifying its public health burden.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      This stage moved our project from concept to <strong>data-driven legitimacy</strong>. The combination of literature, databases, and modeling showed that we were not just proposing an idea, but grounding it in evidence. It also reinforced the choice of MRSA as a representative pathogen while clarifying that our platform remains adaptable to other resistant bacteria.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Integrated AMR/MRSA background into our HP documentation and wiki.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Selected <em>mecA</em> as the model resistance gene with database support.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Published SIRD/competition modeling results in our wiki HP <strong>Responsiveness</strong> section.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='background') }}" target="_blank">Background</a> 路
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='human-practices') }}" target="_blank">iHP responsiveness</a>
    </p>

  </div>
</div>

<!-- Timeline 3: Doctor Interviews -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#doctorModal">
    <span class="circle">4</span>
    <span class="label">Doctor Interviews</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="doctorModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">3. Doctor Interviews</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-4.webp"
           alt="Timeline 3"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      With literature review, database analysis, and epidemiological modeling in place, we turned to <strong>frontline clinicians</strong> for insights into how an anti-MRSA platform might be perceived in real healthcare settings. We conducted on-site interviews at the <strong>Hangzhou Integrative Medicine Hospital</strong>, a leading tertiary hospital in Zhejiang Province. Our interviewee was the <strong>associate director of the infectious diseases department</strong> (name anonymized for privacy).
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Doctors not only face resistant infections daily but also understand the realities of treatment decision-making, patient safety, and regulatory pathways. Their input was critical for aligning our conceptual platform with clinical needs.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To identify doctors鈥?main concerns about applying a DNA origami鈥揅as9 platform.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To understand expectations for safety, effectiveness, and clinical usability.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To reflect as a team on how these concerns should reshape our project design and communication.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">The interview was conducted <strong>face-to-face on site</strong>. We introduced our platform concept and asked about its potential clinical value. The doctor acknowledged the innovation but emphasized several key concerns:
        <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Safety first</strong>: Would the ROS generated by G4鈥揾emin damage host tissue? How could off-target Cas9 activity be minimized?</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Metabolic clearance</strong>: How would the origami structure and Cas9 protein be degraded or removed from the human body?</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Delivery route</strong>: Could the system be applied locally (e.g., lung infections, wound infections) rather than systemically, to reduce risk?</li>
        </ol>
      </li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">After the interviews, our team held an internal reflection meeting to integrate these insights into the design roadmap.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The interviews revealed that clinicians think beyond 鈥渃an it work鈥?to 鈥渋s it safe, controllable, and clinically usable.鈥?Our blueprint had emphasized molecular mechanisms, but doctors reminded us that <strong>translation into practice depends on delivery, clearance, and risk communication</strong>. In our reflection, we realized we must embed safety explanations not only in lab design but also in our public-facing communication.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Added local administration scenarios into our application design.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Began drafting safety texts for wiki and outreach.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Planned additional wet-lab validation for <strong>ROS levels and cytotoxicity</strong>, to demonstrate safety boundaries.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='safety') }}" target="_blank">Safety</a>
    </p>


  </div>
</div>


<!-- Timeline 4: Head Nurse Interview -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#nurseModal">
    <span class="circle">5</span>
    <span class="label">Head Nurse Interview</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="nurseModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">4. Head Nurse Interview</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-5.webp"
           alt="Timeline 4"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Following the doctor interview, we continued our stakeholder engagement at the <strong>Hangzhou Integrative Medicine Hospital</strong>.
      This time, we conducted an <strong>on-site, face-to-face interview</strong> with the <strong>head nurse</strong> (name anonymized for privacy).
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Nurses play a central role in bedside care, drug administration, and patient monitoring.
      Their feedback directly reflects how a novel therapeutic platform could be implemented in real-world practice.
      For us, this interview bridged the gap between conceptual design and <strong>practical usability at the nursing level</strong>.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To understand nurses鈥?expectations regarding usability and workflow.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To evaluate whether our platform could be applied without adding excessive complexity to care.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To explore how wet-lab validation could address these nursing-level concerns.</li>
    </ol>

    <h4>Process</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">During the interview, the head nurse emphasized three concerns:</p>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Ease of use</strong> 鈥?Administration methods should be simple and not require advanced technical training.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Clear instructions</strong> 鈥?Nursing staff rely on practical guidelines: duration of effect, frequency of administration, and handling precautions.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Patient safety</strong> 鈥?Nurses need assurance that the product will not cause unpredictable side effects during use.</li>
    </ol>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In response, our team reflected internally and adjusted our wet-lab roadmap:</p>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Planned <strong>NPN uptake experiments</strong> to quantify bacterial membrane permeability, linking it to 鈥渆ase of delivery.鈥?/li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Designed <strong>Proteinase K protection assays</strong> to test Cas9 stability, ensuring product reliability during handling.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The interview highlighted that <strong>usability is as important as innovation</strong>.
      Without simple, standardized instructions, even the most advanced therapeutic platform would face barriers at the bedside.
      By linking wet-lab data to clinical usability, we learned to design experiments not only for scientific rigor but also for practical validation.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Discuss nursing-friendly application routes (e.g., wound hydrogel, local spray).</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Drafted preliminary templates for frequency, dosage, and handling.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Integrated nursing feedback into our HP communication materials, highlighting usability and patient safety.</li>
    </ol>

  </div>
</div>

<!-- Timeline 5: Communication with BiowiseTech -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#biowiseModal">
    <span class="circle">6</span>
    <span class="label">Communication with BiowiseTech</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="biowiseModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">5. Communication with BiowiseTech and Validation Strategy</h3>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      To explore the industrial feasibility of our DNA origami platform, we communicated with <strong>BiowiseTech</strong>,
      one of the earliest companies in China to commercialize DNA nanostructures.
      Founded in 2017, BiowiseTech specializes in automated origami design, high-throughput synthesis, and modular nanodevices for biomedical applications.
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Through this exchange, we gained valuable insights into <strong>structural stability, protein protection, and membrane penetration assays</strong>鈥攁reas that our original experimental plan had overlooked.
      Their input enabled us to benchmark our project against <strong>industrial expectations of reproducibility, safety, and functionality</strong>.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To understand industry priorities for DNA origami as a delivery system.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To identify missing validation steps in our wet-lab pipeline.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To adapt our functional validation framework for future translational pathways.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Protein cargo protection</strong>: commonly tested using <strong>Proteinase K digestion + SDS-PAGE</strong> to confirm stability.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Membrane penetration</strong>: measured by evaluating ROS-mediated permeability changes, e.g., <strong>NPN uptake assay</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Industry focus</strong>: reproducibility, stability, loading efficiency, release conditions, and biocompatibility are core metrics for commercial development.</li>
    </ul>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Based on these insights, we restructured our experimental validation strategy to include these missing components.
    </p>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Before this exchange, our focus was mainly on <em>mecA</em> gene editing efficiency.
      The company鈥檚 input made us realize that <strong>delivery success itself must be verified</strong>.
      Without proving ROS penetration and protein stability, gene editing claims would lack credibility in clinical or industrial contexts.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Added <strong>NPN uptake experiments</strong> to test ROS-induced membrane permeability.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Designed <strong>Proteinase K protection assays</strong> to evaluate Cas9 stability inside DNA origami.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Incorporated these into our functional validation module for both safety and translation.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='assembly') }}" target="_blank">Wet-Lab NPN</a> 路 
      <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='assembly') }}" target="_blank">Proteinase K Validation</a>
    </p>

  </div>
</div>

<!-- Timeline 6: Pharmacy Director Interview -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#pharmacyModal">
    <span class="circle">7</span>
    <span class="label">Pharmacy Director Interview</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="pharmacyModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">6. Pharmacy Director Interview</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-6.webp"
           alt="Timeline 6"
           style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      We continued our stakeholder engagement at the <strong>Hangzhou Integrative Medicine Hospital</strong>.
      This time, our <strong>on-site, face-to-face interview</strong> was conducted with the <strong>pharmacy director</strong> (name anonymized for privacy).
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Pharmacists are responsible for drug dispensing, medication counseling, and ensuring that patients understand their prescriptions.
      Their perspective reflects how a novel therapeutic platform would be received by patients at the pharmacy counter and how information should be communicated transparently.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To identify pharmacists鈥?concerns about patient acceptance of gene-editing鈥揵ased platforms.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To explore how risk communication should be structured at the dispensing level.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To integrate Dry-Lab visualization tools for clearer public-facing explanations.</li>
    </ol>

    <h4>Process</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Patient trust</strong> 鈥?Many patients are skeptical of 鈥渟ynthetic鈥?or 鈥済ene-editing鈥?solutions. Transparent communication is key.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Side effects</strong> 鈥?Pharmacists need to clearly explain potential risks, metabolism, and clearance pathways.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Information accessibility</strong> 鈥?Explanations should avoid overly technical jargon, focusing instead on intuitive visuals and FAQs.</li>
    </ol>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      In our team reflection, we decided to make Dry-Lab results more accessible:
    </p>

    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Aptamer binding scores and 3D models</strong> were turned into simple visuals to explain targeting specificity.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Membrane permeability simulations</strong> were animated to show how DNA origami safely enters bacteria without affecting human cells.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The interview underscored that <strong>patient acceptance depends on transparency and clarity</strong>.
      A scientifically strong project may still fail if patients fear it.
      By integrating Dry-Lab outputs into risk communication, we turned abstract results into relatable explanations,
      bridging the gap between science and pharmacy-level counseling.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Translated Dry-Lab aptamer and permeability models into <strong>public-friendly visualizations</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Added pharmacist feedback into HP communication strategies.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='model') }}" target="_blank">Aptamer & Permeability Models</a>
    </p>

  </div>
</div>

<!-- Timeline 7: Science Communicator Interview -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#communicatorModal">
    <span class="circle">8</span>
    <span class="label">Science Communicator Interview</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="communicatorModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">7. Science Communicator Interview</h3>

  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" style="display:block; text-align:center; margin:2vh 0;">
  <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-7.webp"
       alt="Timeline 7"
       style="width:80%; max-width:900px; height:auto; border-radius:10px; margin-bottom:2vh;
              box-shadow:0 4px 20px rgba(0,0,0,0.25);">

  <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-8.webp"
       alt="Timeline 7 (extra)"
       style="width:80%; max-width:900px; height:auto; border-radius:10px;
              box-shadow:0 4px 20px rgba(0,0,0,0.25);">
  </div>


    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      To better understand how the general public perceives synthetic biology and gene-editing鈥揵ased platforms, we interviewed a
      <strong>popular Chinese science communicator</strong>, who is currently studying abroad and has built a large online following of 
      <strong>over 300,000 fans</strong> on platforms such as Bilibili. His videos mainly focus on <strong>biotechnology, everyday science myths, and public science education</strong>.
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      Since he was overseas, the interview was conducted <strong>online via video call</strong>, focusing on public misconceptions and communication strategies.
      She emphasized that <strong>public fear often stems from misunderstanding</strong>: many people mistakenly believe gene-editing technologies directly alter human DNA or pose uncontrollable risks.
      These insights encouraged us to rethink not only our wiki explanations but also our broader outreach strategy.
    </p>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">
        The science communicator shared her experiences in running science channels, noting that terms like 鈥済ene editing鈥?and 鈥渟ynthetic biology鈥?
        sound intimidating to lay audiences. Without careful explanation, people imagine scenarios of human genetic modification rather than
        bacterial-targeted interventions.
      </li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">
        Drawing on her media experience, she suggested that we:
        <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Create <strong>short educational animations</strong> comparing natural vs. synthetic products.</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Emphasize in wiki and outreach that our system edits <strong>bacterial resistance genes only</strong>, not human DNA.</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Use simple analogies and visual metaphors (like locks and keys) to explain mechanisms such as ROS generation and DNA origami delivery.</li>
        </ul>
      </li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">
        Inspired by this, we later joined a broader communication initiative: together with <strong>CJUH-JLU-China and 33 other iGEM teams</strong>,
        we co-authored the <strong>鈥淪mashing Synthetic Biology Rumours鈥?brochure</strong>, aiming to clarify misconceptions and reassure the public.
      </li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The interview revealed that science communication is not an 鈥渙ptional extra鈥?but a <strong>core requirement</strong> for societal acceptance.
      By joining a 34-team collaboration, we moved beyond individual outreach and positioned our project as part of a
      <strong>collective effort to normalize synthetic biology in public discourse</strong>.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Produced public-friendly educational materials (animations, FAQ, analogies).</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Revised wiki safety and communication sections to clarify 鈥渘on-human editing.鈥?/li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Co-authored the <strong>鈥淪mashing Synthetic Biology Rumours鈥?brochure</strong> with CJUH-JLU-China and 33 other teams.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='collaborations') }}" target="_blank">Collaboration</a>
    </p>

  </div>
</div>


<!-- Timeline 8: Hangzhou iGEM Exchange -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#exchangeModal">
    <span class="circle">9</span>
    <span class="label">Hangzhou iGEM Exchange</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="exchangeModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">8. Hangzhou iGEM Exchange</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-9.webp"
           alt="Timeline 8" style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-10.webp"
           alt="Timeline 8 extra" style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      At the <strong>Hangzhou iGEM Exchange</strong>, we not only shared our project but also listened to the experiences of past iGEM teams.
      Several teams presented how their projects had successfully <strong>transitioned from competition to industrialization</strong>,
      with some even entering the market as real biotech products.
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      This realization made us aware that <strong>scientific innovation alone is not sufficient</strong>鈥攆or our platform to have real-world impact,
      we also needed to consider <strong>business feasibility, commercialization pathways, and entrepreneurship</strong>.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To learn from past iGEM teams鈥?successful industrialization cases.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To integrate business and market considerations into our project.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To draft the <strong>Entrepreneurship section</strong> for our wiki.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Industrial success often depends on <strong>cost reduction strategies</strong>, <strong>clear value proposition</strong>, and <strong>investor engagement</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">We collaborated with mentors to produce:
        <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>TAM/SAM/SOM analysis</strong> for antimicrobial therapeutics.</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>TRL milestones</strong> and stage assessments.</li>
          <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Market entry strategies</strong> such as hospital collaborations.</li>
        </ul>
      </li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The exchange reshaped our perspective: our project should not only be evaluated by its <strong>scientific feasibility</strong>
      but also by its <strong>commercial viability</strong>. By completing the entrepreneurship documentation, we laid the foundation for
      our project to be viewed not just as a lab prototype but as a potential biotech solution.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Completed the <strong>Entrepreneurship section</strong> of our wiki.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Integrated market analysis (TAM/SAM/SOM, TRL milestones).</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Positioned our project as a <strong>scientific + commercial platform</strong>.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='entrepreneurship') }}" target="_blank">Entrepreneurship</a> 路
      <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='collaborations') }}" target="_blank">Collaboration</a>
    </p>
  </div>
</div>



<!-- Timeline 9: CCiC Meeting Feedback and Safety Revision -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#ccicModal">
    <span class="circle">10</span>
    <span class="label">CCiC Feedback & Safety Revision</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="ccicModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">9. CCiC Meeting Feedback and Safety Revision</h3>

    <p style="text-align:center;">
      <img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/integration-timeline/timeline-11.webp"
           alt="Timeline 9" style="max-width:80%; border-radius:10px; box-shadow:0 4px 20px rgba(0,0,0,0.25);">
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      During the <strong>Nucleic Acid Drug Exchange Meeting</strong> and <strong>Living Therapeutics Exchange Session</strong> at CCiC, 
      our team presented the DNA origami鈥揅as9 platform. Discussions quickly centered on <strong>biosafety</strong>.
    </p>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      It became clear that while our platform was scientifically novel, its <strong>safety documentation was underdeveloped</strong>.
      The exchange directly prompted us to revise our safety framework and collaborate with peers on standardized safety practices.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Address biosafety concerns raised during CCiC discussions.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Strengthen our safety section with structured, evidence-based arguments.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Co-develop standardized safety practices with peer teams.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Risks discussed: <strong>uncontrolled proliferation</strong>, <strong>long-term persistence</strong>, and <strong>off-target effects</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">We realized our safety section must include <strong>specific, evidence-backed frameworks</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Collaborated with <strong>Peking University iGEM</strong> to draft the <strong>Living Therapeutics Safety Form</strong>.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      CCiC discussions showed that biosafety is a <strong>shared responsibility</strong>.  
      By revising our safety documentation and contributing a new Safety Form, we turned a weakness into a community contribution.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Rewrote our wiki safety section with detailed, evidence-based content.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Co-developed the <strong>Living Therapeutics Safety Form</strong> with Peking University.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Incorporated CCiC discussions into our HP storyline as a turning point for safety design.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='safety') }}" target="_blank">Safety</a> 路
      <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='collaboration') }}" target="_blank">Collaboration</a>
    </p>
  </div>
</div>


<!-- Timeline 10: Internal Brainstorming and Future Directions -->
<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="appear" style="text-align:center; margin:4vh 0;">
  <button class="ihp-trigger timeline-btn" data-target="#futureModal">
    <span class="circle">11</span>
    <span class="label">Internal Brainstorming and Future Directions</span>
  </button>
</div>

<div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" id="futureModal" class="ihp-modal modal-overlay">
  <div style="max-width: 100%; box-sizing: border-box; overflow: hidden;" class="modal-content">
    <button class="close-modal" title="Close">&times;</button>

    <h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">10. Internal Brainstorming and Future Directions</h3>

    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      After completing several rounds of stakeholder interviews and external exchanges, our team organized an
      <strong>internal brainstorming session</strong> to synthesize feedback and discuss long-term improvements.
      The aim was to <strong>step back from immediate deliverables</strong> and evaluate how our platform could evolve beyond MRSA,
      reduce costs, and align with the broader vision of building a universal antimicrobial strategy.
    </p>

    <h4>Aims</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To identify potential improvements in cost, safety, and scalability.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To reframe our project as a <strong>platform adaptable to multiple resistant pathogens</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">To generate concrete future milestones for both scientific and HP deliverables.</li>
    </ol>

    <h4>Process</h4>
    <ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Cost reduction</strong>: Inspired by BiowiseTech鈥檚 reference materials, we discussed using
        <strong>phage-based origami self-production</strong> to lower scaffold synthesis costs.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Pathogen adaptability</strong>: While MRSA served as our proof-of-concept, members emphasized generalizing to
        CRE, VRE, and other resistant bacteria鈥攁ligning with the <strong>infectious disease track</strong>.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Safety reinforcement</strong>: Expand the <em>Living Therapeutics Safety Form</em> into a more universal
        <strong>鈥淪afety Bluebook鈥?/strong>, potentially co-authored with multiple teams.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Outreach strategy</strong>: Consider interactive simulations showing origami delivery and ROS generation to demystify the platform.</li>
    </ul>

    <h4>Reflection</h4>
    <p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">
      The brainstorming session transformed scattered feedback into a <strong>coherent long-term roadmap</strong>.
      Our strength lies not only in a single proof-of-concept, but in showing DNA origami as a
      <strong>flexible, cost-effective, and safe antimicrobial delivery platform</strong>.
    </p>

    <h4>Action</h4>
    <ol style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Added <strong>phage-based origami production</strong> to long-term milestones.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Reframed the project as a <strong>universal antimicrobial platform</strong>, with MRSA as the first case.</li>
      <li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Design interactive simulations showing origami delivery and ROS generation.</li>
    </ol>

    <p style="margin-top:1em; text-align:center;">
      馃敆 <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='future') }}" target="_blank">Future</a> 路
      <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="{{ url_for('pages', page='model') }}" target="_blank">Dry-Lab Model</a>
    </p>

  </div>
</div>



<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Entrepreneurship</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">While our stakeholder analysis and iterative timeline focused on scientific, clinical, and social integration, another critical layer soon emerged: <strong>commercial feasibility</strong>. During exchanges such as the Hangzhou iGEM meeting, we learned how past iGEM projects had successfully <strong>transitioned from competition prototypes into real biotech products</strong>. These stories revealed that even the most innovative designs could only generate lasting impact if they were also <strong>economically viable, scalable, and positioned within a clear market pathway</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">For this reason, we gradually embedded a commercial perspective into our Integration framework鈥攏ot as a replacement for science or safety, but as a <strong>complementary dimension</strong>. This awareness helped us evaluate issues such as production cost (e.g., phage-based origami), regulatory approval, and eventual translation into clinical or public health settings. The detailed entrepreneurship content is presented in a dedicated section of our wiki, but here we highlight how commercial thinking was born out of our HP journey and became a natural extension of integration.</p>

<h1 style="color: #ffffff !important; text-shadow: 0 0 50px rgba(96, 165, 250, 1), 0 0 30px rgba(96, 165, 250, 0.9), 0 0 15px rgba(96, 165, 250, 0.7);">Science Communication</h1>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Science communication is an essential component of our project. While our experiments and modeling were designed to develop a universal platform against antimicrobial resistance (AMR), we were fully aware that scientific achievements can only generate real societal impact when they are <strong>understood, trusted, and accepted</strong>. With this in mind, we sought from the very beginning to advance communication in parallel with experimentation. From grassroots education to academic exchanges and cross-team publications, we gradually built a communication pathway that helped our project gain broader understanding and recognition.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Science Outreach Teaching</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">At <strong>Meitan Zhejiang University Primary School</strong>, we conducted a science outreach class introducing the background of our project to a group of curious young students. Through interactive experiments and everyday analogies, we explained the basic concepts of DNA and DNA origami, as well as the role of bacteria, the function of antibiotics, and the causes of resistance.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">The purpose of this activity went beyond simply delivering knowledge; it aimed to cultivate <strong>curiosity, trust, and early scientific literacy</strong>. For many students, this was the first time they had encountered the concept of "antimicrobial resistance." Their responses highlighted that <strong>early engagement in science communication is crucial for the long-term social acceptance of synthetic biology</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-7.webp" alt="Primary School Outreach"></p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Campus Outreach at Zhejiang University</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">At the <strong>Zhejiang University international campus</strong>, we carried out a presentation and discussion aimed at fellow university students. We explained the design of our universal anti-resistance platform and why MRSA was chosen as the model system. At the same time, we also introduced the <strong>iGEM competition itself</strong>, highlighting how synthetic biology connects life sciences, engineering, and societal challenges.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">This outreach fostered <strong>interdisciplinary participation</strong>: students from computer science, design, and business backgrounds showed interest and later contributed in areas such as visualization, data analysis, and business planning. This experience revealed to us that synthetic biology is not reserved for biology students alone but is instead an <strong>open and collaborative discipline that welcomes diverse expertise</strong>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-8.webp" alt="Campus Outreach"></p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Conferences and Exchanges</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We actively participated in a series of iGEM academic exchanges, where we promoted our project, learned from others, and continuously adjusted our communication strategies. Through this process, we gradually developed a <strong>layered communication model</strong>.</p>

<ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;">
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>SUSTech SynBio Exchange (May 31)</strong><br>
Focused mainly on sharing ideas of synthetic biology, especially <strong>dry lab design and modeling pipelines</strong>. Our team <strong>presented only the platform concept</strong>, rather than project details.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Hangzhou iGEMer Exchange (July 26)</strong><br>
Several schools gathered in Hangzhou to share their projects and provide feedback. Mentors offered suggestions for improvement, which directly contributed to upgrading our project.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>Living Therapeutics Exchange (August 4)</strong><br>
Centered on <strong>living therapeutics</strong>. Our team mainly shared the <strong>safety control principles</strong> of living therapeutics and emphasized the safety aspects of our project in communication.</li>
<li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;"><strong>CCiC 鈥?Conference of China iGEMer Community (August 5)</strong><br>
The most challenging communication scenario, with judges, mentors, and other teams present. Here, we systematically applied the <strong>layered narrative model</strong>: the stable story of a "universal AMR platform" remained at the center, while technical detail was expanded or simplified depending on the audience.</li>
</ul>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">These exchanges showed us that communication is not only about presenting a project but also about iterating through feedback. This experience gradually shaped the <strong>layered communication framework</strong> that underpins our wiki writing and outreach.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Collective Public Outreach</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Recognizing the persistence of public misconceptions, we collaborated with <strong>CJUH-JLU-China and 33 other iGEM teams</strong> to co-author the <strong><em>Smashing Synthetic Biology Rumours Science Brochure</em></strong>. This publication targeted common fears, such as "gene editing alters human DNA," and dismantled them with plain explanations, visuals, and references. By transforming communication into a <strong>collective effort</strong>, we amplified both credibility and reach. The brochure circulated widely in iGEM and public science networks. As for the details of Smashing Synthetic Biology Rumours Science Brochure, please see <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="collaborations">Collaboration</a>.</p>

<h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Safety Communication</h2>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">We worked with <strong>Peking University</strong> to draft the <strong><em>iGEM Safety Standard for Engineered Live Biotherapeutic Products (LBPs)</em></strong>. Although designed as a technical guideline, the handbook also functioned as a communication artifact, translating laboratory biosafety protocols into <strong>transparent, standardized formats</strong> accessible to other teams and even non-specialists. In this way, we framed biosafety not as a hidden laboratory detail but as a <strong>shared, communicable standard</strong>, reinforcing public trust in synthetic biology. As for the details of iGEM Safety Standard for Engineered Live Biotherapeutic Products (LBPs), please see <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" href="collaborations">Collaboration</a>.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Together, these activities illustrate how science communication was integrated into every stage of our project. From <strong>early education</strong> in primary schools, to <strong>interdisciplinary outreach</strong> on campus, to <strong>multi-level exchanges</strong> with iGEM teams, and finally to <strong>collective publications</strong>, our communication pathway expanded step by step. Each effort not only strengthened understanding and trust among different audiences but also reinforced our project's identity as an <strong>open, responsible, and collaborative platform</strong>.</p>

<h1 style="color: #ffffff !important; text-shadow: 0 0 50px rgba(96, 165, 250, 1), 0 0 30px rgba(96, 165, 250, 0.9), 0 0 15px rgba(96, 165, 250, 0.7);">Ethic & Engage</h1>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In building a general anti-resistance platform, we not only focus on the technical implementation itself but also use an <strong>Ethical Matrix</strong> to systematically evaluate its potential impacts. As discussed in <em>Improving the Ethical Matrix: Constructing a Tool for Ethical Assessment of Biomedical Technologies</em>, the Ethical Matrix adopts <strong>well-being, autonomy, justice, and safety</strong> as its core principles to organize the concerns of different stakeholders.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Based on early stakeholder analysis and field inquiries, we re-identified several key groups: <strong>patients and clinicians</strong>, <strong>the public and public-health professionals</strong>, <strong>scientists and companies</strong>, and <strong>policymakers</strong>. Building on this, we ran simulation workshops and tried to articulate concerns from different standpoints.</p>

<h3 style="color: #ffffff !important; text-shadow: 0 0 20px rgba(96, 165, 250, 0.6), 0 0 10px rgba(96, 165, 250, 0.4), 0 0 3px rgba(96, 165, 250, 0.2);">Qualitative Analysis and Potential Viewpoints</h3>

<table style="max-width: 100%; box-sizing: border-box; overflow-x: auto; display: block;" style="border-collapse: collapse; width: 100%; text-align: left; font-family: 'Noto Sans', Arial, sans-serif; font-size: 15px;">
  <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;"ead style="background-color: #eaf2f8; color: #1a5276;">
    <tr style="max-width: 100%; box-sizing: border-box;">
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Stakeholder</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Primary Concerns</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Potential Positive Views</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Potential Negative Views</th>
    </tr>
  </thead>
  <tbody>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Patients</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Efficacy, side effects</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">May save lives; fewer antibiotic side effects</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#922b21;">Stability/reliability; unknown consequences</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#f8f9f9;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Healthcare providers</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Comparison with current care</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">More therapeutic options</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#b03a2e;">Added burden of consent and communication</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Public</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Population health impact</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">Reduced societal AMR burden</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#b9770e;">Complex to understand; risk of public anxiety</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#f8f9f9;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Patients across strata</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Fair access</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">Broad benefit if covered by insurance</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#922b21;">High prices may exacerbate inequities</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Companies / Institutions</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Returns & development</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">Drives industrial advancement</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#b03a2e;">Potentially skewed resource allocation</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#f8f9f9;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Policymakers</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Regulatory safeguards</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">Transparent oversight builds trust</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#b9770e;">Lagging regulations hamper timely responses</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color:#fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Scientists</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">Biosafety</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#1e8449;">Controllability; degradable DNA carrier</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color:#922b21;">HGT risks may be underestimated</td>
    </tr>
  </tbody>
</table>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In practice, we drew on the "integrative mode" of the Ethical Matrix, conducted small-scale supplementary inquiries, and organized cross-disciplinary simulation discussions within the team. We then looped these reflections back into project design and external communication.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-9.webp" alt="Ethical Matrix"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">The red markings indicate the roles that the stakeholders played in promoting our project, while the blue markings highlight the limitations on the impact they had through their participation in the activities.</p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/hp-ihp/ihp-10.webp" alt="Stakeholder Analysis"></p>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">In this way, ethical reflection shifts from a one-off assessment to a <strong>cycle of experimentation 鈫?communication 鈫?feedback</strong>, becoming embedded in project evolution. This gradually builds a dynamic mechanism of responsibility and response, ensuring the design is consistent with scientific logic while aligning with social values. On this basis, we further used a <strong>Likert scale (鈭? to +2)</strong> to simulate perceived impacts across four dimensions for different groups:</p>

<table style="max-width: 100%; box-sizing: border-box; overflow-x: auto; display: block;" style="border-collapse: collapse; width: 100%; text-align: center; font-family: 'Noto Sans', Arial, sans-serif; font-size: 15px;">
  <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;"ead style="background-color: #eaf2f8; color: #1a5276;">
    <tr style="max-width: 100%; box-sizing: border-box;">
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Stakeholder</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Well-being</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Autonomy</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Justice</th>
      <th style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px;">Safety</th>
    </tr>
  </thead>
  <tbody>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color: #fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; padding: 8px; font-weight: bold;">MRSA patients</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #1e8449;">+2</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #239b56;">+1</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #1e8449;">+2</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #922b21;">鈭? (risk of side effects)</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color: #f8f9f9;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Clinicians</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #1e8449;">+2</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">0</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #239b56;">+1</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">0</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color: #fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Scientists</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #239b56;">+1</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #1e8449;">+2</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #239b56;">+1</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #922b21;">鈭? (environmental implications)</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color: #f8f9f9;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">Public-health staff</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #1e8449;">+2</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #b9770e;">鈭?</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">0</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #922b21;">鈭? (resistance pressure)</td>
    </tr>
    <tr style="max-width: 100%; box-sizing: border-box;" style="background-color: #fefefe;">
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; font-weight: bold;">General public</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #239b56;">+1</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf;">0</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #b9770e;">鈭?</td>
      <td style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box;" style="border: 1px solid #d6dbdf; color: #922b21;">鈭?</td>
    </tr>
  </tbody>
</table>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">These quantitative scores are not definitive conclusions; rather, they help reveal the <strong>coexistence of benefits and risks</strong>. The technology shows promise for improving individual well-being and therapeutic fairness, yet it requires caution around safety and public acceptance. Introducing the Ethical Matrix not only enables a more systematic view of stakeholder concerns but also allows these reflections to <strong>permeate naturally</strong> into the project's design and communication. As inquiry, discussion, and quantitative appraisal advance, our project establishes a more balanced dialogue between science and society. This process does not end with a single assessment; instead, it provides an internal point of convergence for the <strong>RISE</strong> framework, where feedback from each component can gather and continue forward.</p>

<h1 style="color: #ffffff !important; text-shadow: 0 0 50px rgba(96, 165, 250, 1), 0 0 30px rgba(96, 165, 250, 0.9), 0 0 15px rgba(96, 165, 250, 0.7);">Conclusion</h1>

<p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Through the integration of <strong>Responsiveness, Integration, Science Communication, and Ethics & Engagement</strong>, our project evolved from a conceptual sketch into a comprehensive, data-driven, and socially grounded universal platform against antimicrobial resistance. Each dimension reinforced the others: data justified our design, stakeholder feedback refined our approach, communication built trust, and ethical reflection ensured responsibility. This journey demonstrates that impactful synthetic biology requires not only scientific innovation but also <strong>deep engagement with society, stakeholders, and ethical frameworks</strong>.</p>


<script src="{{ url_for('static', filename='ihp.js')}}"></script>








</div>
  </main>

  <script src="/assets/js/main.js"></script>
  <footer class="site-footer">
    <img src="/assets/images/logo6.webp" alt="椤佃剼鍥剧墖">
  </footer>
</body>
</html>

